applied 10X Visium on 4 TNBC samples, showing that KLF5 expression co‐localised with basal markers (KRT5, KRT14, KRT17) in tumour regions, while areas with reduced KLF5 expression were enriched with CD4+ and CD8+ T cells. This evidence concerns the gene KLF5 and neoplasm.